SleepImage

What SleepImage does

SleepImage (legally MyCardio, LLC, a Colorado LLC) develops and commercializes an FDA-cleared Software as a Medical Device (SaMD) for home sleep testing. Its proprietary Cardiopulmonary Coupling (CPC) analysis measures health during sleep from the Autonomic Nervous System by analyzing the synchronization between heart rate variability and respiration derived from ECG/PPG signals. The system is FDA-cleared to establish sleep quality, diagnose Sleep Disordered Breathing in children (age 2+) and adults, and manage SDB, with output validated as comparable to polysomnography. The product portfolio consists of two finger-worn hardware form factors (the SleepImage Ring for multi-patient use and the SleepImage Fingertip for single-patient treatment tracking) that capture six channels of raw physiological data streamed via Bluetooth to a patient-facing mobile app and automatically uploaded to a HIPAA-compliant cloud-based Clinical Portal for clinician review and diagnosis.

The company serves licensed healthcare professionals across multiple specialties, including sleep specialists, cardiologists, pulmonologists, pediatricians, neurologists, and primary care physicians. Its go-to-market is sales-led and prescription-based: clinicians register on the platform (providing clinic and NPI details), order hardware for their patients, and use the Clinical Portal to interpret automated reports, perform manual scoring, and write clinical notes. Revenue is generated through durable hardware device sales (Ring and Fingertip) combined with recurring access to the cloud-based SaMD platform, with Remote Patient Monitoring capabilities supporting ongoing engagement and treatment tracking.

SleepImage operates globally with localized presence in the United States, United Kingdom, Australia, Canada, the European Union, Singapore, and South Africa. It also operates a Research Access program and a Developer Interest program backed by an SDK License Agreement, supporting clinical research partnerships (notably with the Sleep Research Society Foundation in 2024) and potential integration with third-party healthcare technology providers. The company is privately held, bootstrapped with no disclosed external funding, and operates with a small leadership team spanning CEO, CTO, CMO, CFO, SVP Sales/Marketing, SVP Market Development, and VP Sales functions.

Name

SleepImage

Legal name

MyCardio, LLC

Website

https://sleepimage.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

SleepImage (MyCardio, LLC) sells an FDA-cleared Software as a Medical Device that uses proprietary Cardiopulmonary Coupling analysis to enable home sleep testing and sleep apnea diagnosis in children and adults, serving licensed healthcare professionals across multiple specialties globally.

Ownership category

akta.pro rank

Product category

Home Sleep Diagnostics and Sleep Medicine Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Services-Prepackaged Software (7372)

akta.pro industry

PRIMARYHLAHAGAB

Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

SECONDARYCRACAIAG

Sleep Tech Wearables

Consumer Products & Retail/Consumer Electronics & Appliances Retail/Wearables & Personal Tech Retail

Keywords

• Home sleep testing
• Sleep apnea diagnosis
• Medical device software
• Cardiopulmonary coupling
• Sleep quality monitoring

Headquarters

HQ city

Denver

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Hardware Device Sales: SleepImage Ring and Fingertip devices sold to healthcare providers and patients. The Ring is intended for multi-patient use while the Fingertip is for single-patient use. Devices are reusable and do not require consumables, creating a durable goods revenue model.
2. Software as a Medical Device (SaMD) Access: Cloud-based SleepImage System provided as access to healthcare professionals. The FDA-cleared SaMD analyzes sleep data and generates automated reports for diagnosis and management of sleep disorders.
3. Remote Patient Monitoring: The system supports Remote Patient Monitoring capabilities, enabling clinicians to engage patients in their own care and track sleep quality and sleep apnea treatment over time.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

SleepImage provides FDA-cleared home sleep testing solutions built on proprietary Cardiopulmonary Coupling (CPC) analysis technology. The offering includes finger-worn hardware devices (Ring for multi-patient use, Fingertip for single-patient use), a patient-facing mobile app for data capture, and a cloud-based Clinical Portal for clinicians. The system measures sleep quality, sleep duration, and diagnoses sleep disordered breathing in children (age 2+) and adults with accuracy comparable to in-lab polysomnography.

Product overview

SleepImage offers a unified home sleep testing ecosystem consisting of FDA-cleared Software as a Medical Device (SaMD) backed by proprietary Cardiopulmonary Coupling (CPC) technology. The portfolio includes two hardware form factors—the SleepImage Ring (multi-patient use, available in adult and pediatric versions) and the SleepImage Fingertip (single-patient use for treatment tracking)—paired with a patient-facing Mobile App that streams data via Bluetooth and automatically uploads to the cloud-based Clinical Portal for clinician review. The system captures 6 channels of raw physiological data and delivers automated, FDA-cleared output comparable to polysomnography for sleep apnea diagnosis and sleep quality assessment. Research Access enables researchers to leverage the platform's analytical capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• SleepImage System (SaMD) FDA-cleared Software as a Medical Device (SaMD) that measures sleep quality, diagnoses sleep apnea, and manages sleep disordered breathing in children (age 2+) and adults using Cardiopulmonary Coupling (CPC) analysis. Output is comparable to polysomnography (PSG) for sleep apnea diagnosis and is designed for use by licensed healthcare professionals.
• SleepImage Ring Finger-worn wearable hardware device intended for multi-patient use, available in adult (PO2) and child (PO4) versions. Supports single or multi-night testing and is designed for patient comfort with a single point of contact, capturing 6 channels of physiological data during sleep for transmission to the SleepImage System SaMD.
• SleepImage Fingertip Single-patient use finger-worn device (PO6) designed for treatment tracking. Includes 3 SleepImage System Reports. Worn on finger to capture physiological data during sleep and is intended for ongoing monitoring of sleep therapy effectiveness.
• SleepImage Mobile App Patient-facing mobile application for iOS and Android that enables home sleep testing. Patients create accounts, pair recording devices via Bluetooth, start/stop sleep studies, and data is automatically uploaded to the clinician's Clinical Portal for review and diagnosis.
• SleepImage Clinical Portal Cloud-based secure portal for healthcare professionals to review patient sleep study data, interpret results, write clinical notes, and manage patient care. Data is automatically uploaded from patient mobile apps after sleep studies and automatically analyzed to generate reports for review and diagnosis.
• SleepImage Research Access Cloud-based access to the SleepImage System for clinical research purposes. Enables researchers to analyze large datasets collected during sleep and conduct prospective or retrospective studies using the FDA-cleared CPC technology, including through the SRSF grant program partnerships.

Quantifiable outcome

• sAHI (Sleep Apnea Hypopnea Index) comparable to PSG-derived AHI for sleep apnea diagnosis with strong correlation (Pearson coefficients of 0.972)
• +3 more outcomes

Named customers1 record

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Partnerships

One partnership is on record.

• Sleep Research Society Foundation (SRSF)coreStrategic or Co-development Partner · 1 March 2024SleepImage partnered with the Sleep Research Society Foundation to offer grant opportunities for researchers. The 2024 grant programs included 'Sleep Equity for Global Health' and 'Pediatric Sleep Research' programs. Grant recipients receive SleepImage data collection devices (up to 20 multi-patient devices) and research access to the SleepImage System for clinical studies. This partnership supports innovation in sleep health research and advances the clinical validation of CPC technology.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• ResMed: ResMed is the global leader in sleep apnea therapy (CPAP) and also offers the ApneaLink Air home sleep testing device. While SleepImage competes with ResMed's HSAT product, ResMed is a broad incumbent whose dominant franchise is sleep apnea therapy rather than diagnostics, and benefits from bundled therapy-plus-diagnostic selling.
• Natus Medical: Natus Medical offers PSG and related neurodiagnostic equipment (Embla, Xltek brands) used in sleep labs and neurology clinics. It is a broad incumbent in clinical sleep and neurodiagnostic monitoring, overlapping with SleepImage in sleep specialist and lab customers, though its focus extends beyond sleep into broader neurodiagnostics.
• Philips Respironics: Philips offers the Alice series of PSG and HSAT systems alongside its dominant CPAP therapy franchise. As a broad incumbent, Philips competes with SleepImage in sleep diagnostics while leveraging a much larger installed base, hospital relationships, and integrated respiratory care portfolio.

Direct peers

• Nox Medical: Nox Medical manufactures the Nox T3 and related PSG/home sleep testing systems used by sleep labs and clinicians globally. It is a direct competitor in the sleep diagnostics hardware + software market, with a comparable B2B GTM to sleep specialists and similar product positioning around multi-channel physiological data capture.
• Itamar Medical (ZOLL Itamar): Itamar Medical (acquired by ZOLL/ResMed) is the most direct peer, offering WatchPAT — a finger-worn home sleep apnea test that uses PAT (peripheral arterial tone) technology. Both companies compete head-to-head in home sleep testing with finger-worn hardware, FDA-cleared diagnostic output, and similar clinician-targeted GTM motions.
• Compumedics: Compumedics manufactures PSG, HSAT, and EEG systems sold globally to sleep labs and clinicians. It is a direct peer in clinical sleep diagnostics with overlapping customer segments (sleep specialists, hospitals, research institutions) and similar hardware-plus-software product architecture.
• CleveMed: CleveMed offers SleepView and other home sleep testing devices marketed to clinicians and sleep labs. It is a direct peer in the HSAT space with finger-worn and chest-worn hardware options targeting the same cardiology, pulmonology, and primary care channels as SleepImage.

Emerging players

• Oura: Oura offers a consumer smart ring with sleep tracking and has been expanding into health and wellness features with research partnerships. It is an emerging player in ring-form-factor sleep wearables, sharing form-factor similarity with the SleepImage Ring, but operating in a consumer/consumer-wellness channel rather than as an FDA-cleared diagnostic.
• Withings: Withings offers consumer sleep tracking via Sleep Analyzer (under-mattress) and ScanWatch, with a newer B2B health solutions push. It is an emerging player at the intersection of consumer wearables and clinical-grade sleep measurement, adjacent to SleepImage's wearable ring approach but primarily consumer-channel rather than clinician-channel.
• BMC Medical: BMC Medical manufactures both HSAT/PSG diagnostic devices and CPAP/APAP therapy devices, with strong presence in China and growing global reach. It overlaps with SleepImage in the home sleep testing category and serves similar pulmonology and primary care channels, but competes primarily on integrated therapy-plus-diagnostic bundling.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/sleepimage

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SleepImage